SPECIAL ARTICLE
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle

https://doi.org/10.1097/00004583-199604000-00008Get rights and content

ABSTRACT

Objective

To evaluate the scope of the available therapeutic armamentarium in attention-deficit hyperactivity disorder (ADHD).

Method

The literature of medication trials in ADHD was systematically reviewed, with attention to issues of psychiatric comorbidity, age, gender, and ethnic background.

Results

One hundred fifty-five controlled studies of 5,768 children, adolescents, and adults have documented the efficacy of stimulants in an estimated 70% of subjects. The literature clearly documents that stimulants not only improve abnormal behaviors of ADHD, but also self-esteem, cognition, and social and family function. However, response varied in different age groups and with certain comorbid conditions. In addition, there is an impressive body of literature documenting the efficacy of tricyclic antidepressants on ADHD in more than 1,000 subjects. Studies of alternative antidepressants, antipsychotics, antihypertensives, and other compounds were also reviewed.

Conclusions

The available literature indicates the important role of psychophar-macological agents in the reduction of the core symptoms of ADHD and associated impairments. More research is needed on alternative pharmacological treatments and to further evaluate established therapeutics beyond school-age Caucasian boys. In addition, more research is needed on the efficacy of treatment for comorbid ADHD, use of combined medications, and the combination of medication and psychosocial treatment.

REFERENCES (202)

  • J Biederman et al.

    Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder

    J Am Acad Child Adolesc Psychiatry

    (1990)
  • B Birmaher et al.

    Methylphenidate treatment of hyperactive autistic children

    J Am Acad Child Adolesc Psychiatry

    (1988)
  • BG Borcherding et al.

    Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?

    Psychiatry Res

    (1990)
  • E Caine et al.

    Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol

    J Am Acad Child Psychiatry

    (1984)
  • DE Comings et al.

    Tourette's syndrome and attention deficit disorder with hyperactivity: are they genetically related?

    J Am Acad Child Psychiatry

    (1984)
  • HW Coons et al.

    Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing

    J Am Acad Child Adolesc Psychiatry

    (1987)
  • CK Deutsch et al.

    Genetic latent structure analysis of dysmorphology in attention deficit disorder

    J Am Acad Child Adolesc Psychiatry

    (1990)
  • V Douglas et al.

    Do high doses of stimulants impair flexible thinking in ADHD?

    J Am Acad Child Adolesc Psychiatry

    (1995)
  • G DuPaul et al.

    Response of children with ADHD to methylphenidate: interaction with internalizing symptoms

    J Am Acad Child Adolesc Psychiatry

    (1994)
  • J Elia et al.

    Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

    Psychiatry Res

    (1991)
  • P Firestone et al.

    The effects of caffeine and methylphenidate on hyperactive children

    J Am Acad Child Psychiatry

    (1978)
  • K Gadow et al.

    Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings

    J Am Acad Child Adolesc Psychiatry

    (1992)
  • KD Gadow et al.

    Methylphenidate in agressive-hyperactive boys: I. Effects on peer aggression in public school settings

    J Am Acad Child Adolesc Psychiatry

    (1990)
  • BD Garfinkel et al.

    Tricyclic antide-pressant and methylphenidate treatment of attention deficit disorder in children

    J Am Acad Child Psychiatry

    (1983)
  • M Gross

    Imipramine in the treatment of minimal brain dysfunction in children

    Psychosomatics

    (1973)
  • MD Gross

    Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome

    Psychosomatics

    (1975)
  • L Hechtman

    Long-term outcome in attention-deficit hyperactivity disorder

    Psychiatr Clin North Am

    (1992)
  • RD Hunt et al.

    An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder

    J Am Acad Child Adolesc Psychiatry

    (1995)
  • RD Hunt et al.

    Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial

    J Am Acad Child Psychiatry

    (1985)
  • S Jaffe

    Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD

    J Am Acad Child Adolesc Psychiatry

    (1991)
  • H Abikoff et al.

    Hyperactive children treated with stimulants

    Arch Gen Psychiatry

    (1985)
  • H Abikoff et al.

    The normalizing effects of methylphenidate on the classroom behavior of ADDH children

    J Abnorm Child Psychol

    (1985)
  • Adler L, Resnick S, Kunz M, Devinsky O (1995), Open-label trial of venlafaxine in attention deficit disorder. Presented...
  • A Alexandris et al.

    Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children

    Can Med Assoc J

    (1968)
  • RA Barkley

    A review of stimulant drug research with hyperactive children

    J Child Psychol Psychiatry

    (1977)
  • RA Barkley

    The ecological validity of laboratory and analogue assessment methods of ADHD symptoms

    J Abnorm Child Psychol

    (1991)
  • RA Barkley et al.

    The effects of methylphenidate on the mother–child interactions of hyperactive children

    Arch Gen Psychiatry

    (1979)
  • RA Barkley et al.

    Effects of age and Ritalin dosage on mother–child interactions of hyperactive children

    J Consult Clin Psychol

    (1984)
  • M Befera et al.

    Hyperactive and normal girls and boys: mother–child interactions, parent psychiatric status, and child psychopathology

    J Child Psychol Psychiatry

    (1985)
  • A Bergman et al.

    Methylphenidate: effects on sustained attention

  • J Biederman et al.

    Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder (ADHD): patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples

    Arch Gen Psychiatry

    (1992)
  • J Biederman et al.

    Desipramine in the treatment of children with attention deficit disorder

    J Clin Psychopharmacol

    (1986)
  • Biederman J, Milberger S, Faraone S et al. (1994), Family environmental risk factors for attention deficit...
  • J Biederman et al.

    Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

    Am J Psychiatry

    (1991)
  • J Biederman et al.

    Estimation of the association between desipramine and the risk for sudden death in 5-to 14-year-old children

    J Clin Psychiatry

    (1995)
  • J Biederman et al.

    Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder

    Am J Psychiatry

    (1995)
  • RT Brown et al.

    A controlled trial of methylphenidate in black adolescents

    Clin Pediatr (Phila)

    (1988)
  • Brown TE, Gammon GD (1992), ADHD-associated difficulties falling asleep and awakening: clonidine and methylphenidate...
  • M Campbell et al.

    Child and Adolescent Psychopharmacology

    (1985)
  • CD Casat et al.

    Bupropion in children with attention deficit disorder

    Psychopharmacol Bull

    (1989)
  • Cited by (0)

    View full text